Skip to main content
. Author manuscript; available in PMC: 2021 Jul 21.
Published in final edited form as: J Am Coll Cardiol. 2020 Jul 21;76(3):292–302. doi: 10.1016/j.jacc.2020.05.045

Table 4.

Secondary Outcomes

Outcome N (%) 90% Confidence Interval Details
Cutaneous neonatal lupus 4/63 (6.4%) 2.2% - 13.9% Occurred at 3, 5, 6 and 12 weeks after birth
Weights below normal gestational age (<±2 standard deviations) 1/63 (1.6%) 0.08% - 7.3% Born to a mother with SLE/SS weight=1.995 kg at 37 weeks
Premature birth 9/63 (14.3%) 7.7% - 23.6%
Premature rupture of membranes 2/9 35 weeks, SLE/SS; 35 weeks, UAS
Low amniotic fluid & intrauterine growth restriction 2/9 35 weeks, SLE/SS; 35 weeks, UAS
Pre-eclampsia 1/9 36 weeks, SLE
Placental insufficiency 1/9 32 weeks, SLE
Placental abruption 1/9 35 weeks, SS
Partial placenta previa with recurrent bleeding 1/9 35 weeks, SLE/SS
Vaginal bleeding of unknown cause 1/9 36 weeks, UAS
*

SLE=systemic lupus erythematosus; SS=Sjogren’s syndrome; UAS=undifferentiated autoimmune syndrome